News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare Disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

NORD Submits Comments to the Centers for Medicare and Medicaid Services
MDedge Endocrinology
NORD Call for Abstracts Reopened
MDedge Endocrinology
National Health Council to Host Workshop for Patient Organizations
MDedge Endocrinology
Think about breast cancer surveillance for transgender patients
MDedge Endocrinology
FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Endocrinology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Endocrinology
VIDEO: Few transgender patients desire care in a transgender-only clinic
MDedge Endocrinology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Endocrinology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Endocrinology
RFPs Available for the Study of Three Rare Diseases
MDedge Endocrinology